Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alan S. Forman Insider Profile
4 Followers
Alan S. Forman, Director at Stemline Therapeutics, holds 5.00K shares in JBG Smith Properties (Ticker: JBGS), holds 0.00 shares in Stemline Therapeutics (Ticker: STML), holds 0.00 shares in Acadia Realty (Ticker: AKR). Most recently, Alan S. Forman Bought ― shares of JBG Smith Properties on May 11, 2022 for an estimated value of 121.61K.
Alan S. Forman Stemline Therapeutics (STML)Director
Stemline Therapeutics (STML)
Director
Not Ranked
Ranked #92,607 out of 98,743 Corporate Insiders
Alan S. Forman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Alan S. Forman holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 11, 2022 - May 11, 2023
Return:-35.80%
The most profitable trade made by Alan S. Forman
Alan S. Forman's Trading History
Stemline Therapeutics
Jun 10, 2020
―
Uninformative Sell
―
$0.00
JBG Smith Properties
May 11, 2022
Director
Informative Buy
121.61K
$73.30K
Acadia Realty
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Alan S. Forman's performance on stock
You May Also Like
Alan S. Forman insider profile FAQ
What is the percentage of profitable transactions made by Alan S. Forman?
The percentage of profitable transactions made by Alan S. Forman is ―.
What is the average return per transaction made by Alan S. Forman?
The average return per transaction made by Alan S. Forman is ―.
What stocks does Alan S. Forman hold?
Alan S. Forman holds: STML, JBGS, AKR stocks.
What was Alan S. Forman’s latest transaction?
Alan S. Forman latest transaction was an Informative Buy of $121.61K.
What was Alan S. Forman's most profitable transaction?
Alan S. Forman’s most profitable transaction was an Informative Buy of JBGS stock on May 11, 2022. The return on the trade was -35.80%.
What is Alan S. Forman's role in Stemline Therapeutics?
Alan S. Forman's role in Stemline Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.